ArticleFrontiers in pharmacology2024

Dual inhibition of MEK and PI3Kβ/δ-a potential therapeutic strategy in PTEN-wild-type docetaxel-resistant metastatic prostate cancer.

Vicenç Ruiz de Porras et al.PubMed ↗Full text ↗Publisher ↗

No numbers read from the abstract.